Sign In
Buy ALPN
$64.97
+0 (+0%)
At Close: Aug 19, 2024
Alpine Immune Sciences (ALPN) Gets a Buy Rating from Oppenheimer - Markets
10:01pm, Thursday, 18'th Jun 2020
Oppenheimer analyst Mark Breidenbach maintained a Buy rating on Alpine Immune Sciences (ALPN – Research Report) today and set a
Alpine Immune Sciences : Surges 168% on AbbVie Agreement for ALPN-101 | MarketScreener
05:06pm, Thursday, 18'th Jun 2020Stocks, Oil on the Mend Amid Volatile Day - Schaeffer's Investment Research
03:56pm, Thursday, 18'th Jun 2020
All three major indexes came back from this morning's losses with marginal gains midday, but investors anxieties over coronavirus and jobless claims linger
P/E Ratio Insights for Alpine Immune Sciences
02:22pm, Thursday, 18'th Jun 2020
In the current session, Alpine Immune Sciences Inc. (NASDAQ: ALPN) is trading at $9.87, after a 102.67% increase. Over the past month, the stock increased by 194.10%, and in the past year, by 123.24%.
Alpine Immune Sciences : , AbbVie in Option and License Agreement for ALPN-101 | MarketScreener
12:41pm, Thursday, 18'th Jun 2020ALPINE IMMUNE SCIENCES, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure (form 8-K) | MarketScreener
12:06pm, Thursday, 18'th Jun 2020Alpine Immune Sciences and AbbVie Announce Option and License Agreement for the Development and Commercialization of ALPN-101
12:00pm, Thursday, 18'th Jun 2020
Alpine Immune Sciences and AbbVie Announce Option and License Agreement for the Development and Commercialization of ALPN-101
Alpine Immune Sciences and AbbVie Announce Option and License Agreement for the Development and Commercialization of ALPN-101
12:00am, Thursday, 18'th Jun 2020
Alpine Immune Sciences and AbbVie Announce Option and License Agreement for the Development and Commercialization of ALPN-101
Oppenheimer Issues a Buy Rating on Iovance Biotherapeutics (IOVA) - Markets
03:53am, Tuesday, 16'th Jun 2020
In a report released yesterday, Mark Breidenbach from Oppenheimer assigned a Buy rating to Iovance Biotherapeutics (IOVA – Research Report),
Alpine Immune Sciences : Announces ALPN-202 Poster Presentation at AACR Virtual Annual Meeting II | MarketScreener
12:02pm, Monday, 15'th Jun 2020Alpine Immune Sciences Announces ALPN-202 Poster Presentation at AACR Virtual Annual Meeting II
12:00pm, Monday, 15'th Jun 2020
Alpine Immune Sciences Announces ALPN-202 Poster Presentation at AACR Virtual Annual Meeting II
Alpine Immune Sciences' Shares March Higher, Can It Continue?
10:57am, Thursday, 11'th Jun 2020
As of late, it has definitely been a great time to be an investor in Alpine Immune Sciences.
Hedge Funds Never Been Less Bullish On Alpine Immune Sciences, Inc. (ALPN)
07:44pm, Wednesday, 10'th Jun 2020
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
